食品安全质量检测学报
食品安全質量檢測學報
식품안전질량검측학보
FOOD SAFETY AND QUALITY DETECTION TECHNOLOGY
2015年
2期
614-618
,共5页
赵岩%妙志岩%郜玉钢%刘双利%杨鹤%张连学%王士杰
趙巖%妙誌巖%郜玉鋼%劉雙利%楊鶴%張連學%王士傑
조암%묘지암%고옥강%류쌍리%양학%장련학%왕사걸
人参茸芝胶囊%半数致死量(LD50)%最大耐受量(MTD)
人參茸芝膠囊%半數緻死量(LD50)%最大耐受量(MTD)
인삼용지효낭%반수치사량(LD50)%최대내수량(MTD)
Renshen Rongzhi capsule%median lethal doses%maximum tolerance dosage
目的:研究人参茸芝胶囊的急性毒性,评价人参茸芝胶囊的安全性。方法根据中药、天然药物急性毒性实验技术指导原则,将60只小鼠按体质量随机分为给药组和空白对照组,禁食不禁水12 h后,给药组将人参茸芝胶囊以最大浓度(2.2 g?mL?1),最大体积(40 mL?kg?1)灌胃给药,空白对照组以等容积的蒸馏水灌胃给药,连续14 d观察小鼠体质量、行为活动以及死亡情况。14 d后处死所有小鼠,观察小鼠心、肝、肾、脑等脏器是否正常。结果给药组小鼠无1例死亡,与对照组比较,给药组小鼠的体质量变化和进食量无显著差异,行为活动无异常。尸解后未见给药组小鼠的脏器异常。小鼠的人参茸芝胶囊的半数致死量(LD50)未测得,最大耐受量(MTD)为88 g?kg?1。结论从药物急性毒性研究结果来看,人参茸芝胶囊是一个安全的剂型。
目的:研究人參茸芝膠囊的急性毒性,評價人參茸芝膠囊的安全性。方法根據中藥、天然藥物急性毒性實驗技術指導原則,將60隻小鼠按體質量隨機分為給藥組和空白對照組,禁食不禁水12 h後,給藥組將人參茸芝膠囊以最大濃度(2.2 g?mL?1),最大體積(40 mL?kg?1)灌胃給藥,空白對照組以等容積的蒸餾水灌胃給藥,連續14 d觀察小鼠體質量、行為活動以及死亡情況。14 d後處死所有小鼠,觀察小鼠心、肝、腎、腦等髒器是否正常。結果給藥組小鼠無1例死亡,與對照組比較,給藥組小鼠的體質量變化和進食量無顯著差異,行為活動無異常。尸解後未見給藥組小鼠的髒器異常。小鼠的人參茸芝膠囊的半數緻死量(LD50)未測得,最大耐受量(MTD)為88 g?kg?1。結論從藥物急性毒性研究結果來看,人參茸芝膠囊是一箇安全的劑型。
목적:연구인삼용지효낭적급성독성,평개인삼용지효낭적안전성。방법근거중약、천연약물급성독성실험기술지도원칙,장60지소서안체질량수궤분위급약조화공백대조조,금식불금수12 h후,급약조장인삼용지효낭이최대농도(2.2 g?mL?1),최대체적(40 mL?kg?1)관위급약,공백대조조이등용적적증류수관위급약,련속14 d관찰소서체질량、행위활동이급사망정황。14 d후처사소유소서,관찰소서심、간、신、뇌등장기시부정상。결과급약조소서무1례사망,여대조조비교,급약조소서적체질량변화화진식량무현저차이,행위활동무이상。시해후미견급약조소서적장기이상。소서적인삼용지효낭적반수치사량(LD50)미측득,최대내수량(MTD)위88 g?kg?1。결론종약물급성독성연구결과래간,인삼용지효낭시일개안전적제형。
ABSTRACT:Objective To investigate the acute toxicity and evaluate the safety of Renshen Rongzhi capsule.Methods According to the technical guidelines for the acute toxicity experiment on traditional Chinese medicine and natural medicine, 60 mice were randomly divided into treatment group and control group. After fasting but not restraining water for 12 h, Renshen Rongzhi capsule at a maximum concentration (2.2 g?mL?1) and maximum capacity (40 mL?kg?1) were given ig in the treatment group, while distilled water to the control group. After administration, mice were free to forage and water for 14 d and the body weight and behavioral events and circumstances of the death were recorded, after 14 d, all animals were killed and autopsied. Then the internal organs were observed, which included heart, liver, kidney, and brain.Results The mortality was 0 in the treatment group. Compared with the treatment group, the changes of the food intake and the body weight were not significantly different in the treatment group. The general conditions of animals were not abnormal in the treatment group. After the gross anatomy, the appearance of organ showed no abnormality. The LD50of mice Renshen Rongzhi capsule could not be measured, the maximum tolerance dosage (MTD) was 88 g?kg-1, respectively.Conclusion Based on the medicinal toxic experimental results, Renshen Rongzhi capsule is a kind of safe form.